News
BRIBF
0.304
NaN%
--
Weekly Report: what happened at BRIBF last week (0407-0411)?
Weekly Report · 5d ago
Weekly Report: what happened at BRIBF last week (0331-0404)?
Weekly Report · 04/07 10:36
Weekly Report: what happened at BRIBF last week (0324-0328)?
Weekly Report · 03/31 10:45
Weekly Report: what happened at BRIBF last week (0317-0321)?
Weekly Report · 03/24 10:36
Weekly Report: what happened at BRIBF last week (0310-0314)?
Weekly Report · 03/17 10:43
Weekly Report: what happened at BRIBF last week (0303-0307)?
Weekly Report · 03/10 10:45
Weekly Report: what happened at BRIBF last week (0224-0228)?
Weekly Report · 03/03 10:44
Weekly Report: what happened at BRIBF last week (0217-0221)?
Weekly Report · 02/24 10:44
Weekly Report: what happened at BRIBF last week (0210-0214)?
Weekly Report · 02/17 10:42
Weekly Report: what happened at BRIBF last week (0203-0207)?
Weekly Report · 02/10 10:38
Weekly Report: what happened at BRIBF last week (0127-0131)?
Weekly Report · 02/03 10:41
Weekly Report: what happened at BRIBF last week (0120-0124)?
Weekly Report · 01/27 10:43
Weekly Report: what happened at BRIBF last week (0113-0117)?
Weekly Report · 01/20 10:37
Weekly Report: what happened at BRIBF last week (0106-0110)?
Weekly Report · 01/13 10:38
Weekly Report: what happened at BRIBF last week (1230-0103)?
Weekly Report · 01/06 10:43
Weekly Report: what happened at BRIBF last week (1223-1227)?
Weekly Report · 12/30/2024 10:39
Weekly Report: what happened at BRIBF last week (1216-1220)?
Weekly Report · 12/23/2024 10:44
Weekly Report: what happened at BRIBF last week (1209-1213)?
Weekly Report · 12/16/2024 10:45
Weekly Report: what happened at BRIBF last week (1202-1206)?
Weekly Report · 12/09/2024 10:44
Weekly Report: what happened at BRIBF last week (1125-1129)?
Weekly Report · 12/02/2024 10:44
More
Webull provides a variety of real-time BRIBF stock news. You can receive the latest news about Brii Biosciences through multiple platforms. This information may help you make smarter investment decisions.
About BRIBF
Brii Biosciences Ltd is a biotechnology company principally focused on developing therapies for infectious diseases and central nervous system diseases. The Company's HBV portfolio products include the proprietary therapeutic vaccine BRII-179, the siRNA BRII-835 (elebsiran), and the neutralizing antibody BRII-877 (tobevibart). The Company owns a broad pipeline of multiple innovative drug candidates that focus on infectious diseases and central nervous system diseases. The Company’s products are applied in infectious diseases, such as hepatitis B virus (HBV), human immunodeficiency virus (HIV), multi-drug resistant (MDR) or drug resistant (XDR) gram-negative infections, and other illnesses, such as the central nervous system (CNS) diseases. The Company mainly conducts its businesses in China market.